Regulation FD Disclosure (Form 8-K)

Item 7.01. Regulation FD Disclosure.

As previously disclosed, on June 25, 2026, ASP Isotopes Inc., a Delaware corporation ("ASPI" or the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement"), by and among ENDRA Life Sciences Inc., a Delaware corporation ("ENDRA"), Noble Africa LLC, a Delaware limited liability company and a direct, wholly-owned subsidiary of the Company ("Noble Africa"), Renergen Limited, a company incorporated under the laws of the Republic of South Africa and a direct, wholly-owned subsidiary of the Company ("Renergen"), the Company, and Kruger Merger Sub LLC, a Delaware limited liability company and a direct, wholly-owned subsidiary of ENDRA ("Merger Sub"), pursuant to which, among other matters, and subject to the satisfaction or waiver of the conditions set forth in the Merger Agreement, Merger Sub will merge with and into Noble Africa (the "Merger"), with Noble Africa surviving the Merger as a direct wholly-owned subsidiary of ENDRA.

On October 2, 2026, ENDRA filed a Registration Statement on Form S-4 (the "Registration Statement") relating to the proposed Merger, which contained important information about Renergen. The information contained in the Registration Statement is incorporated by reference herein. ENDRA may file subsequent amendments to the Registration Statement and additional filings related to the proposed Merger with the Securities and Exchange Commission ("SEC"), which will be available on the SEC's website at www.sec.gov.

The information in this Item 7.01 shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended (the "Securities Act"), and shall not be incorporated by reference into any filing with the SEC (including under the Exchange Act or the Securities Act), whether made by the Company before or after the date hereof, regardless of any general incorporation language in such filing.